Kayla A Huber1,1, Madison Sunnquist2, Leonard A Jason3. 1. Center for Community Research, DePaul University, 990 W. Fullerton Ave. Suite 3101, Chicago, IL 60614, kayla.a.huber@gmail.com; 2. Center for Community Research, DePaul University, 990 W. Fullerton Ave. Suite 3101, Chicago, IL 60614, msunnqui@depaul.edu; 3. Center for Community Research, DePaul University, 990 W. Fullerton Ave. Suite 3101, Chicago, IL 60614, ljason@depaul.edu;
Abstract
BACKGROUND: Individuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) routinely display differences in symptomatology, as well as illness course, onset, duration, and functional disability. Given such diversity, previous work has attempted to identify symptom-based ME/CFS subtypes. However, results have been inconsistent. PURPOSE: This study sought to elucidate potential subtypes of ME/CFS as well as explore the impact of subtype membership on health functioning. METHODS: Twelve non-core (i.e., less frequently endorsed) symptoms were included in a latent class analysis of 1,210 adults with ME/CFS. Demographic and illness-related predictors of class membership were evaluated with a multinomial logistic regression. ANOVAs were then performed to determine if there were significant differences across class on the eight subscales of the Short-Form Health Survey (SF-36). RESULTS: A six-class solution was selected, which consisted of one class that was likely to endorse all non-core symptoms, one class that was unlikely to endorse any non-core symptoms, and four classes that were likely to endorse either one or two non-core symptom domains (i.e., circulatory/neuroendocrine impairment, orthostatic intolerance, and gastro-intestinal distress). Significant functioning differences by class were present for all SF-36 subscales. CONCLUSIONS: These results are suggestive of subtypes of ME/CFS and, if replicated, may assist physicians in providing tailored treatment to patients and allow researchers to form more homogeneous samples.
BACKGROUND: Individuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) routinely display differences in symptomatology, as well as illness course, onset, duration, and functional disability. Given such diversity, previous work has attempted to identify symptom-based ME/CFS subtypes. However, results have been inconsistent. PURPOSE: This study sought to elucidate potential subtypes of ME/CFS as well as explore the impact of subtype membership on health functioning. METHODS: Twelve non-core (i.e., less frequently endorsed) symptoms were included in a latent class analysis of 1,210 adults with ME/CFS. Demographic and illness-related predictors of class membership were evaluated with a multinomial logistic regression. ANOVAs were then performed to determine if there were significant differences across class on the eight subscales of the Short-Form Health Survey (SF-36). RESULTS: A six-class solution was selected, which consisted of one class that was likely to endorse all non-core symptoms, one class that was unlikely to endorse any non-core symptoms, and four classes that were likely to endorse either one or two non-core symptom domains (i.e., circulatory/neuroendocrine impairment, orthostatic intolerance, and gastro-intestinal distress). Significant functioning differences by class were present for all SF-36 subscales. CONCLUSIONS: These results are suggestive of subtypes of ME/CFS and, if replicated, may assist physicians in providing tailored treatment to patients and allow researchers to form more homogeneous samples.
Entities:
Keywords:
chronic fatigue syndrome; health functioning; latent class analysis; myalgic encephalomyelitis; subtypes
Authors: Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King Journal: Neuropsychol Rev Date: 2005-03 Impact factor: 7.444
Authors: Bonnie B Dean; Daniel Aguilar; Victoria Barghout; Kristijan H Kahler; Feride Frech; David Groves; Joshua J Ofman Journal: Am J Manag Care Date: 2005-04 Impact factor: 2.229
Authors: L A Jason; J A Richman; A W Rademaker; K M Jordan; A V Plioplys; R R Taylor; W McCready; C F Huang; S Plioplys Journal: Arch Intern Med Date: 1999-10-11
Authors: A Wilson; I Hickie; D Hadzi-Pavlovic; D Wakefield; G Parker; S E Straus; J Dale; D McCluskey; G Hinds; A Brickman; D Goldenberg; M Demitrack; T Blakely; S Wessely; M Sharpe; A Lloyd Journal: Aust N Z J Psychiatry Date: 2001-08 Impact factor: 5.744
Authors: Lisa M Benrud-Larson; Melanie S Dewar; Paola Sandroni; Teresa A Rummans; Jennifer A Haythornthwaite; Phillip A Low Journal: Mayo Clin Proc Date: 2002-06 Impact factor: 7.616
Authors: J R Kerr; B Burke; R Petty; J Gough; D Fear; D L Mattey; J S Axford; A G Dalgleish; D J Nutt Journal: J Clin Pathol Date: 2007-12-05 Impact factor: 3.411